1. Home
  2. MYGN vs FSBW Comparison

MYGN vs FSBW Comparison

Compare MYGN & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

SELL

Current Price

$4.08

Market Cap

372.1M

Sector

Health Care

ML Signal

SELL

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

SELL

Current Price

$44.65

Market Cap

332.6M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
MYGN
FSBW
Founded
1991
1936
Country
United States
United States
Employees
N/A
537
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
372.1M
332.6M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
MYGN
FSBW
Price
$4.08
$44.65
Analyst Decision
Hold
Hold
Analyst Count
9
3
Target Price
$4.05
★ $45.00
AVG Volume (30 Days)
★ 2.0M
25.8K
Earning Date
11-02-2026
10-23-2026
Dividend Yield
N/A
★ 2.61%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 2.07
Revenue
★ $771,400,000.00
$4,612,000.00
Revenue This Year
N/A
$4.43
Revenue Next Year
$5.47
$8.22
P/E Ratio
★ N/A
$21.43
Revenue Growth
2.33
★ 44.80
52 Week Low
$2.74
$36.66
52 Week High
$8.59
$45.85

Technical Indicators

Market Signals
Indicator
MYGN
FSBW
Relative Strength Index (RSI) 53.52 53.13
Support Level $2.89 $42.84
Resistance Level $4.89 $44.83
Average True Range (ATR) 0.24 0.87
MACD -0.02 -0.01
Stochastic Oscillator 22.78 49.45

Price Performance

Historical Comparison
MYGN
FSBW

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of First Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: